NCT00921245View on ClinicalTrials.gov

FREEDOM - First Real-Life Evaluation of Enablex Done in ZA Overactive Bladder Patients During a 3 Months Period

CompletedOBSERVATIONAL

Enrollment

9

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

February 28, 2009

Conditions

Overactive Bladder

Interventions

DRUG

Darifenacin (Emselex, BAY79-4998)

Patients in daily clinical treatment receiving Emselex according to local drug information

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY